Saira Ramasastry

Director

Saira Ramasastry has served as a member of our Board since September 2019. 

She founded and is the Managing Partner of Life Sciences Advisory, LLC, an independent impact firm focused on accelerating cures for patients in need. 

Prior to founding Life Sciences Advisory, Ms. Ramasastry spent 10 years as an investment banker with Merrill Lynch & Co., Inc., where she helped establish the biotechnology practice and was responsible for the origination of mergers and acquisitions, and strategic and capital markets transactions. Previously, she served as a financial analyst in the mergers and acquisitions group at Wasserstein Perella & Co. 

Ms. Ramasastry currently serves on the board of directors for DayOne Biopharmaceuticals, Inc., Glenmark Pharmaceuticals Ltd. and Mirum Therapeutics, Inc. She is the business and sustainability lead for several Innovative Medicines Initiative programs, and is also a Health Innovator Fellow of the Aspen Institute and a member of the Aspen Global Leadership Network.

Ms. Ramasastry holds a B.A. in economics and an M.S. in management science and engineering from Stanford University. She also holds an M.Phil. in management studies from the University of Cambridge.